⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT May 6, 2026

Azelastin POS 1 mg/ml Nasenspray, Lösung 1,0 mg/ml (Nasenspray, Lösung)

📷 Wikipedia: Azelastine · Source
Azelastin POS 1 mg/ml Nasenspray, Lösung 1,0 mg/ml (Nasenspray, Lösung)
📷 Wikipedia: Azelastine · Source
Azelastine 1 mg/ml nasal spray, solution Increased demand. Affected packs: 10 ml multi-dose bottle [Unavailable since 6 May 2026, resupply 15 June 2026].
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 128 days ago.
📈 Timeline
32 days in total
May 18, 2026 June 19, 2026

What is this? Azelastin is a nasal spray used to treat allergies. It helps with runny noses and sneezing.

What's happening? There is a shortage of this spray. It has been unavailable since May 2026 and is expected back in mid-June 2026.

Does this affect me? If you use this nasal spray, you may not be able to get it right now.

What should I do? Ask your pharmacist or doctor for advice on other treatments while you wait.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
AZELASTIN HYDROCHLORID
Agency-published detail

ATC: R01AC03 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Ursapharm Ges.m.b.H., Inkustraße 1-7, 3400 Klosterneuburg, Österreich · Affected packs: 10 ml Schachtel, Mehrdosenbehältnis [Nicht verfügbar, since 2026-05-06, resupply 2026-06-15]

First published
May 6, 2026
Last refreshed by us
2 months ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 2 months ago

Allergodil 0,5 mg/ml Augentropfen 0,5 mg/ml (Augentropfen, Lösung)

Allergodil 0.5 mg/ml eye drops are temporarily unavailable due to a manufacturing delay. The affected packs are the 6 ml box and bottle.
High AT 2 months ago

Dymista 137 Mikrogramm/50 Mikrogramm pro Sprühstoß Nasenspray, Suspension 137 Mikrogramm/50 Mikrogramm pro Sprühstoß (Nasenspray, Suspension)

Parallel export is banned.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Azelastin POS 1 mg/ml Nasenspray, Lösung 1,0 mg/ml (Nasenspray, Lösung). Azelastine 1 mg/ml nasal spray, solution Increased demand. Affected packs: 10 ml multi-dose bottle [Unavailable since 6 May 2026, resupply 15 June 2026].
▸ When was this alert issued?
This alert was issued on May 6, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.